GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (NSE:APLLTD) » Definitions » 5-Year Share Buyback Ratio

Alembic Pharmaceuticals (NSE:APLLTD) 5-Year Share Buyback Ratio : -0.60% (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Alembic Pharmaceuticals's current 5-Year Share Buyback Ratio was -0.60%.

NSE:APLLTD's 5-Year Share Buyback Ratio is ranked better than
66.53% of 711 companies
in the Drug Manufacturers industry
Industry Median: -2.9 vs NSE:APLLTD: -0.60

Competitive Comparison of Alembic Pharmaceuticals's 5-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alembic Pharmaceuticals's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alembic Pharmaceuticals's 5-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alembic Pharmaceuticals's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Alembic Pharmaceuticals's 5-Year Share Buyback Ratio falls into.


;
;

Alembic Pharmaceuticals 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Alembic Pharmaceuticals (NSE:APLLTD) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Alembic Pharmaceuticals 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alembic Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals Headlines

No Headlines